A Phase 1 Healthy Volunteer Dose Escalation to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Intravenous Human IgG1 Fc-F241A (NVG-2089) for the Treatment of CIDP

A Review of Mental Health Outcomes in Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Pulmonary Involvement in Patients with Contactin-1 IgG Associated Autoimmune Nodopathy